CRL · Categories · Form 4

CRL - SEC Form 4 insider transactions

Charles River Laboratories International Inc. (CRL) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CRL

• 9h
  Director Foster James C gifted 183,361 shares and received a gift of 183,361 shares, decreasing direct ownership by 62% to 106,596 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 9h
  Chief Executive Officer Girshick Birgit gifted 3,386 shares and received a gift of 3,386 shares, decreasing direct ownership by 9% to 36,013 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 9h
  CEVP, Disc & Safety Assessment Parisotto Shannon M gifted 1,529 shares and received a gift of 1,529 shares, decreasing direct ownership by 13% to 9,853 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 5d
  Director Barg Steven was granted 422 shares, increasing direct ownership by 15% to 3,287 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 6d
  EVP & Chief Financial Officer Coleman Glenn was granted 6,640 shares, increasing direct ownership by 31% to 27,752 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 6d
  EVP, Chief Information Officer Mintz Mark was granted 2,534 shares and covered exercise/tax liability with 369 shares, increasing direct ownership by 29% to 9,546 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 6d
  EVP, Corp Strategy & Develop Laplume Joseph W was granted 5,257 shares and covered exercise/tax liability with 979 shares, increasing direct ownership by 16% to 31,298 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 6d
  SVP, Finance and CAO Knell Michael Gunnar was granted 1,837 shares and covered exercise/tax liability with 200 shares, increasing direct ownership by 11% to 16,152 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 6d
  Chief Executive Officer Girshick Birgit was granted 9,961 shares and covered exercise/tax liability with 1,582 shares, increasing direct ownership by 27% to 39,399 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 6d
  Director Foster James C covered exercise/tax liability with 1,596 shares, decreasing direct ownership by 0.57% to 279,957 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 6d
  EVP & Chief People Officer Creamer Victoria L was granted 5,135 shares and covered exercise/tax liability with 810 shares, increasing direct ownership by 17% to 30,051 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 6d
  CEVP, Disc & Safety Assessment Parisotto Shannon M was granted 4,361 shares and covered exercise/tax liability with 721 shares, increasing direct ownership by 47% to 11,382 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 11d
  EVP & Chief People Officer Creamer Victoria L covered exercise/tax liability with 346 shares, decreasing direct ownership by 1% to 25,726 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 11d
  CEVP, Disc & Safety Assessment Parisotto Shannon M gifted 7,169 shares, received a gift of 7,169 shares and covered exercise/tax liability with 273 shares, decreasing direct ownership by 49% to 7,742 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 11d
  EVP, Chief Information Officer Mintz Mark covered exercise/tax liability with 111 shares, decreasing direct ownership by 1% to 7,381 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 11d
  Chief Executive Officer Girshick Birgit covered exercise/tax liability with 618 shares, decreasing direct ownership by 2% to 31,020 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 11d
  SVP, Finance and CAO Knell Michael Gunnar covered exercise/tax liability with 87 shares, decreasing direct ownership by 0.60% to 14,515 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 11d
  EVP, Corp Strategy & Develop Laplume Joseph W covered exercise/tax liability with 428 shares, decreasing direct ownership by 2% to 27,020 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 25d
  Director Andrews Nancy C gifted 3,964 shares and received a gift of 3,964 shares, decreasing direct ownership by 73% to 1,438 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 27d
  Director Barg Steven was granted 1,438 shares, increasing direct ownership by 101% to 2,865 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 27d
  Director Thompson Craig B. was granted 1,438 shares, increasing direct ownership by 60% to 3,851 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 27d
  Director Graves Paul W was granted 1,438 shares, increasing direct ownership by 152% to 2,384 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 28d
  Director Ceesay Abraham was granted 1,438 shares, increasing direct ownership by 152% to 2,384 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 28d
  Director Mackay Martin was granted 2,845 shares, increasing direct ownership by 20% to 17,137 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 28d
  Director Andrews Nancy C was granted 1,438 shares, increasing direct ownership by 36% to 5,402 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 28d
  Director Llado George Sr. was granted 1,888 shares, increasing direct ownership by 39% to 6,702 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 28d
  Director Enyedy Mark J was granted 1,438 shares, increasing direct ownership by 152% to 2,384 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 28d
  Director Kemps-Polanco Reshema was granted 1,973 shares, increasing direct ownership by 76% to 4,563 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 28d
  Director Wilson Virginia M was granted 1,438 shares, increasing direct ownership by 29% to 6,349 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 28d
  Director Foster James C was granted 1,860 shares, increasing direct ownership by 0.67% to 281,553 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 35d
  EVP & Chief Financial Officer Coleman Glenn was granted 21,112 shares (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 95d
  Corporate Executive VP & COO Girshick Birgit gifted 328 shares (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 96d
  Chairman, President and CEO Foster James C was granted 16,796 shares, increasing direct ownership by 6% to 279,693 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 125d
  EVP, Corp Strategy & Develop Laplume Joseph W was granted 5,456 shares and covered exercise/tax liability with 1,749 shares, increasing direct ownership by 16% to 27,423 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 125d
  EVP & Chief People Officer Creamer Victoria L was granted 5,006 shares and covered exercise/tax liability with 1,296 shares, increasing direct ownership by 17% to 26,072 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 126d
  Chairman, President and CEO Foster James C covered exercise/tax liability with 14,664 shares and was granted 39,031 shares, increasing direct ownership by 11% to 253,677 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 126d
  Corporate Executive VP & COO Girshick Birgit was granted 9,500 shares and covered exercise/tax liability with 3,061 shares, increasing direct ownership by 31% to 26,913 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 126d
  CSVP, CAO, Interim CFO Knell Michael Gunnar was granted 1,668 shares and covered exercise/tax liability with 526 shares, increasing direct ownership by 8% to 14,602 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 126d
  EVP, Chief Information Officer Mintz Mark was granted 1,797 shares and covered exercise/tax liability with 655 shares, increasing direct ownership by 18% to 7,492 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 126d
  CEVP, Disc & Safety Assessment Parisotto Shannon M was granted 4,236 shares and covered exercise/tax liability with 1,067 shares, increasing direct ownership by 26% to 15,184 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 139d
  EVP, Corp Strategy & Develop Laplume Joseph W sold $65,488 worth of shares (400 units at $163.72), decreasing direct ownership by 2% to 23,716 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 213d
  CSVP, CAO, Interim CFO Knell Michael Gunnar was granted 2,926 shares, increasing direct ownership by 28% to 13,460 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 292d
  EVP, Corp Strategy & Develop Laplume Joseph W sold $126,080 worth of shares (800 units at $157.60), decreasing direct ownership by 3% to 24,116 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 304d
  EVP, Corp Strategy & Develop Laplume Joseph W sold $60,016 worth of shares (400 units at $150.04), decreasing direct ownership by 2% to 24,916 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 364d
  EVP, Corp Strategy & Develop Laplume Joseph W gifted 385 shares, decreasing direct ownership by 1% to 25,316 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 369d
  Director Ceesay Abraham was granted 946 shares (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 369d
  Director Enyedy Mark J was granted 946 shares (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 369d
  Director Graves Paul W was granted 946 shares (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 369d
  Director Barg Steven was granted 1,427 shares (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 370d
  Corporate Executive VP & CFO Pease Flavia was granted 7,152 shares and covered exercise/tax liability with 185 shares, increasing direct ownership by 67% to 17,297 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 370d
  CEVP, Disc & Safety Assessment Parisotto Shannon M was granted 5,603 shares and covered exercise/tax liability with 105 shares, increasing direct ownership by 73% to 12,997 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 370d
  EVP, Corp Strategy & Develop Laplume Joseph W covered exercise/tax liability with 155 shares and was granted 6,709 shares, increasing direct ownership by 34% to 25,701 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 370d
  CSVP&Chief Accounting Officer Knell Michael Gunnar was granted 2,064 shares and covered exercise/tax liability with 273 shares, increasing direct ownership by 20% to 10,534 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 370d
  Corporate Executive VP & COO Girshick Birgit was granted 12,239 shares and covered exercise/tax liability with 283 shares, increasing direct ownership by 22% to 65,944 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 370d
  EVP & Chief People Officer Creamer Victoria L was granted 6,252 shares and covered exercise/tax liability with 120 shares, increasing direct ownership by 38% to 22,362 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 370d
  Chairman, President and CEO Foster James C was granted 17,253 shares, increasing direct ownership by 9% to 210,685 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 375d
  Corporate Executive VP & CFO Pease Flavia covered exercise/tax liability with 331 shares, decreasing direct ownership by 3% to 10,330 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 375d
  CEVP, Disc & Safety Assessment Parisotto Shannon M covered exercise/tax liability with 213 shares, decreasing direct ownership by 3% to 7,499 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 375d
  EVP, Corp Strategy & Develop Laplume Joseph W covered exercise/tax liability with 366 shares, decreasing direct ownership by 2% to 19,147 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 375d
  CSVP&Chief Accounting Officer Knell Michael Gunnar covered exercise/tax liability with 112 shares, decreasing direct ownership by 1% to 8,743 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)

Other CRL categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends